Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Achillion Pharmaceuticals, Inc. (NQ: ACHN)
8.238 USD  +0.228 (+2.84%)
Streaming Delayed Price  /  Updated: 2:15 PM EDT, Jun 19, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Achillion Pharmaceuticals, Inc.
 
< Previous 1 2 3 4 5 6 Next >
Achillion Announces Private Placement of $50 Million
August 18, 2010
from GlobeNewswire News Releases
Achillion Reports Second Quarter and Six Month Financial Results
August 13, 2010
from GlobeNewswire News Releases
Achillion Pharmaceuticals Announces Nomination of NS5A Inhibitor as a Lead Clinical Candidate for Treatment ff HCV
July 22, 2010
ACH-2928 Demonstrates Excellent Potency Against HCV RNA Replication, Holds Potential for Combination Therapy Read More
from GlobeNewswire News Releases
Achillion to Present at Upcoming Conference
June 03, 2010
from GlobeNewswire News Releases
Biopharma Stock Alert for Achillion Pharmaceuticals Inc. Issued by MicroStockProfit
May 13, 2010
from GlobeNewswire News Releases
Achillion Announces Positive Once-Daily Dosing Results With ACH-1625 to Treat Hepatitis C
May 11, 2010
from GlobeNewswire News Releases
Achillion Reports First Quarter Financial Results
May 10, 2010
from GlobeNewswire News Releases
Achillion Presents Data From Studies of ACH-1625 in Hepatitis C at the EASL International Liver Congress
April 15, 2010
ACH-1625 Achieves Significant Viral Load Reduction and Sustained Viral Suppression With Continued Safety and Tolerability Read More
from GlobeNewswire News Releases
Achillion Announces Award of NIH Grant to Study Unique Antibacterial Compound Series
March 18, 2010
from GlobeNewswire News Releases
Achillion to Present ACH-1625 Protease Inhibitor Abstracts at International Liver Congress
March 16, 2010
from GlobeNewswire News Releases
Achillion Reports 2009 Fourth Quarter and Year-End Financial Results
March 12, 2010
from GlobeNewswire News Releases
Achillion to Present at Upcoming Investor Conferences
March 05, 2010
from GlobeNewswire News Releases
21st Annual Analyst Conference Taking Place March 12th, 2010 at The University Club (54th & 5th Ave)
February 23, 2010
from Business Wire News Releases
Achillion Announces Positive 96-Week Data for Elvucitabine at the 17th Annual Conference on Retroviruses and Opportunistic Infections
February 17, 2010
from GlobeNewswire News Releases
Achillion to Present at 12th Annual BIO CEO and Investor Conference
February 08, 2010
from GlobeNewswire News Releases
Achillion Announces Closing of Underwriters' Over-Allotment Option
February 02, 2010
from GlobeNewswire News Releases
Achillion Announces License Agreement for Elvucitabine Development in China
February 01, 2010
from GlobeNewswire News Releases
Skymark Research Initiates Independent Research Coverage on Achillion Pharmaceuticals, Inc.
January 29, 2010
from GlobeNewswire News Releases
Achillion Announces Nomination of ACH-2684 as Lead Clinical Candidate in Resistance-Focused HCV Program
January 28, 2010
Compound Demonstrates Excellent Potency Against HCV and Retains Activity Against Resistant Variants Read More
from GlobeNewswire News Releases
Achillion to Host Corporate and Clinical Update Conference Call on Monday, February 1, 2010
January 25, 2010
from GlobeNewswire News Releases
Achillion Prices $21.4 Million Public Offering of Common Stock
January 22, 2010
from GlobeNewswire News Releases
Achillion Announces Proposed Public Offering of Common Stock
January 21, 2010
from GlobeNewswire News Releases
Pharmaceutical Stock Alert for Achillion Pharmaceuticals Inc. Issued by StockPreacher
January 12, 2010
from GlobeNewswire News Releases
Pappas Ventures Names Michael Grey Venture Partner
January 11, 2010
from Business Wire News Releases
Achillion Announces Additional Positive Phase 1b Data With ACH-1625 to Treat Hepatitis C
January 11, 2010
Second Dosing Cohort Achieves 4.25log10 Viral Load Reduction With Continued Safety and Tolerability Read More
from GlobeNewswire News Releases
Market Pulse Breaking News Alert for Thursday, December 17, 2009: RMCP -- CT Scan Cancer Revelation Makes Need for RevMed's MRI Technology Critical and RevMed Partners in One of the World's Largest Sy
December 17, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Market Pulse Read More
from Marketwired News Releases
Stock Watch: Beacon Equity Issues Market Alert for Achillion Pharmaceuticals Inc.
December 17, 2009
from GlobeNewswire News Releases
(OTC: USOG) Expanding Its Core Business Through Acquisition
December 16, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by the IO News Wire. Read More
from Marketwired News Releases
PicksThatMove.com Announces Investment Opinion on Achilion Pharmaceuticals Inc., FGX International Holdings Limited, Golden Star Resources, Options Media Group Holdings Inc. and Adobe Systems Incorpor
December 16, 2009
from Business Wire News Releases
Achillion Announces Positive Preliminary Phase 1b Proof of Concept Data With ACH-1625 to Treat Hepatitis C
December 15, 2009
Achieves 3.94 log10 Reduction in HCV RNA With Continued Safety and Tolerability Read More
from GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here